Patents by Inventor Michael L. Glode

Michael L. Glode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9321820
    Abstract: The present invention provides methods and compositions for treating bladder cancer. In particular, the present invention provides a fusion protein comprising a toxin moiety that is linked to an epithelial growth factor (EGF) moiety. The toxin moiety and the EGF moiety can be linked optionally via a linker. Typically, the fusion protein is administered intravesically into the cancerous bladder.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: April 26, 2016
    Assignees: The Regents of the University of Colorado, Scott & White Healthcare
    Inventors: Thomas Flaig, Arthur E. Frankel, Andrew Thorburn, Michael L. Glode